stress urinary incontinence

Regenerative medicine-based treatment with injection of autologous muscle-derived or adipose-derived stem cells for the management of stress urinary incontinence : two preclinical models

Regenerative medicine-based treatment with injection of autologous muscle-derived or adipose-derived stem cells for the management of stress urinary incontinence : two preclinical models

Urinary incontinence (UI) is extremely common (30-50% in female and 5-15% in male subjects) in all the world, able to significantly

impact on the quality of life of patients. It is also associated to a great distress influencing social life with high costs for both patients

and society (1,2). In particular, stress urinary incontinence (SUI) is related to urethral sphincter dysfunction . In male patients SUI is

mainly a complication of radical prostatectomy (RP) procedure for prostate cancer (PC)

Sexual function after pelic organ prolapse surgery. Trocarless Transvaginal Mesh (TTMS) vs. laparoscopic transperitoneal pelvic organ prolapse suspension

Stress urinary incontinence (SUI) and low urinary tract symptoms related to pelvic organs prolapse represent a common condition that negatively impacts on female sexuality (FS). The repair of this anatomical/functional condition could affect female sexual function. Laparoscopic approach known as “pelvic organ prolapse surgery” (POPs) or the anterior repair with a trocar-less trans-vaginal mesh (TTMs) represent two different surgical techniques to reach functional and sexual improvements.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma